3 assets in Micropapillary Serous Carcinoma

Therapeutic assets addressing Micropapillary Serous Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Letrozole Micropapillary Serous Carcinoma	Gynecologic Oncology Group	P2/3	BB (66)
Pembrolizumab Micropapillary Serous Carcinoma	North Eastern German Society of Gynaecological Oncology	P2	CCC (53)
Ribociclib Micropapillary Serous Carcinoma	Gynecologic Oncology Group	P2	CCC (53)